The potential benefit of stem cell therapy after stroke: An update

Citations of this article
Mendeley users who have this article in their library.


Stroke is a leading cause of death and disability worldwide. Stem cell therapy is an emerging therapeutic modality with evidence of significant benefits in preclinical stroke models. A number of phase I and II clinical trials have now been completed, with several more currently under way. Translation to the bedside, however, remains a long way off, and there are many questions that remain unanswered. This review will summarize the current evidence and ongoing clinical trials worldwide, and explore the challenges to making this a realistic treatment option for the future. © 2012 Banerjee et al, publisher and licensee Dove Medical Press Ltd.

Author supplied keywords




Banerjee, S., Williamson, D. A., Habib, N., & Chataway, J. (2012). The potential benefit of stem cell therapy after stroke: An update. Vascular Health and Risk Management, 8(1), 569–580.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free